Overview
Viseven is a MarTech agency that provides digital services for pharma and life sciences, helping brands design and run omnichannel content experiences. It builds digital operating models that deliver content across channels like email, social media, and websites to engage healthcare professionals. The company uses AI and ML to optimize when messages are sent and to measure engagement, offering end-to-end solutions for clients at any stage of digital maturity. Its strengths include a pharma-focused approach, a 700-person team, and a step-by-step guide to help clients improve efficiency, user experience, brand awareness, and HCP loyalty.
Work here?Claim your company
Simplify's take
What believers are saying
- October 22, 2026 eWizard release cuts claim-checking time and rebuilds approved content faster.
- March 12, 2026 AWS ISV Accelerate expands cloud co-sell reach and procurement simplicity.
- Horizon Capital's January 16, 2024 investment validates growth, profitability, and more than tripled revenue since 2019.
What critics are saying
- Salesforce and AWS integrations deepen platform dependence; either partner can disintermediate Viseven by 2027.
- Aprimo, Veeva, and native SaaS features commoditize Viseven's services, compressing margins immediately.
- If pharma clients standardize on in-house AI content ops, Viseven's agency layer becomes redundant.
What makes Viseven unique
- eWizard and eVa AI package regulated content creation, MLR traceability, and distribution together.
- June 25, 2026 Salesforce Agentforce 360 partnership embeds Viseven inside life-sciences CRM workflows.
- Lexi and Kheiron extend Viseven beyond content into congress and field execution intelligence.
Help us improve and share your feedback! Did you find this helpful?